Am J Transplant, Volume 16, Suppl 3 Archives - Page 104 of 180 - ATC Abstracts

2016 American Transplant Congress
Plasma Endothelial Microvesicle Counts Indicate Allograft Rejection Following Kidney Transplantation.
D. Zecher,¹ A. Cumpelik,² B. Ruhland,¹ B. Banas,¹ H. Hopfer,³ M. Dickenmann,⁴ J. Schifferli.²
¹Nephrology, Regensburg University Hospital, Regensburg, Germany; ²Biomedicine, Basel University Hospital, Basel, Switzerland; ³Pathology, Basel University Hospital, Basel, Switzerland; ⁴Nephrology, Basel University Hospital, Basel, Switzerland.
Background: The release of surface-derived microvesicles (MV) is a common phenomenon of cellular activation and occurs specifically as a consequence of terminal complement complex assembly…
2016 American Transplant Congress
Clinical Analysis of Patients with Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation.
D. Kim, G. Na, T. Hong, Y. You.
Surgery, Seoul St. Mary's Hospital, Catholic University, Seoul, Korea.
Purpose: For living-donor liver transplantation (LDLT), there has been a tendency to accept extended criteria in comparison with deceased-donor liver transplantation (DDLT). However, HCC recurrence…
2016 American Transplant Congress
Outcomes of Ductoplasty in Right Lobe Living Donor Grafts with More Than One Bile Duct.
S. Kapoor, V. Varma, B. Nath, V. Kumaran.
Liver Transplantation & HPB Surgery, Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute, Mumbai, Maharashtra, India.
Background:Biliary complications remain the Achilles's heel of LDLT, especially in the setting of multiple ducts in the right lobe graft. Hilar plate glissonian sheath preservation…
2016 American Transplant Congress
Eculizumab for Chronic Antibody-Mediated Injury in Kidney Transplant Recipients: A Randomized-Controlled Trial.
S. Kulkarni,¹ N. Kirkiles-Smith,² Y. Deng,³ R. Formica,⁴ M. Gilbert,⁵ V. Broeckner,⁶ L. Bow,¹ J. Pober.²
¹Surgery, Yale University, New Haven, CT; ²Immunobiology, Yale University, New Haven, CT; ³Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, CT; ⁴Medicine, Yale University, New Haven, CT; ⁵Pathology, Yale University, New Haven, CT; ⁶Histopathology, Univeristy of Cambridge, Cambridge, United Kingdom.
Purpose: We hypothesize that de novo donor specific antibody (DSA) in kidney transplant patients cause endothelial cell injury that is dependent on complement and treatment…
2016 American Transplant Congress
Cold Ischemia Induced Outcomes in Kidney Transplantation: A Meta-Analysis.
D. Bennett, M. Mustafa, M. Chiles, W. Skillen, S. Mohan.
Columbia University Medical Center, New York, NY.
Objective: To examine the association between cold ischemia time (CIT) and delayed graft function (DGF) and death-censored graft failure in kidney transplantation.Methods: To identify relevant…
2016 American Transplant Congress
Do Morbidly Obese Patients Have an Increased Risk of Infection Post-Kidney Transplant?
S. Strout, N. Pilch, T. Veasey, R. Miller, J. Fleming, H. Meadows, C. Mardis, B. Mardis, P. Baliga, A. Posadas, J. McGillicuddy, D. Taber.
Medical University of South Carolina, Charleston, SC.
Purpose: Obesity has been associated with significant morbidity in the kidney transplant population. The aim of this study was to assess the impact of obesity…
2016 American Transplant Congress
United States versus Australia: Is "Percentage Decline in Estimated Glomerular Filtration Rate" Truly a Surrogate Outcome in Graft Survival?
K. Parker,² A. Rice,¹ A. Kirby,¹ M. Pinion,¹ K. Parker.²
¹Internal Medicine Division of Nephrology and Hypertension, East Carolina University, Greenville, NC; ²Internal Medicine, Vidant Medical Center, Greenville, NC.
Purpose: A previous study conducted in Australia and New Zealand examined the utility of estimated glomerular filtration rate (eGFR) decline as a surrogate marker for…
2016 American Transplant Congress
Predictors of Outcomes After Kidney Transplantation in the Setting of Chronic Opiate Use.
R. Evans,¹ N. Neville,² A. Fugit,³ R. Gedaly,¹ T. Clifford.¹
¹University of Kentucky Healthcare, Lexington, KY; ²University of Kentucky College of Pharmacy, Lexington, KY; ³Vidant Medical Center, Greenville, NC.
Purpose: To determine the impact and correlation of pre-transplant chronic opiate use with post-transplant chronic opiate use, resource utilization, and patient survival in addition to…
2016 American Transplant Congress
Differences in the Prevalence of Food Allergies After Liver and or Bowel Transplantation.
K. Khan, C. Desai, S. Kaufman, A. Kroemer, J. Hawksworth, R. Girlanda, T. Fishbein, C. Matsumoto.
Transplant Institute, MedStar Georgetown University Hospital, Washington, DC.
BackgroundFood allergies are reported after transplantation of solid organs in children. We have recently reported an increase in the prevalence of esophageal eosinophilic disease in…
2016 American Transplant Congress
MHC/HLA-Specific IgE in Allotransplantation.
A. Farkas,¹ U. Baranyi,¹ L. Unger,¹ B. Mahr,¹ K. Hock,¹ N. Pilat,¹ H. Regele,² M. Wahrmann,³ G. Böhmig,³ R. Valenta,⁴ T. Wekerle.¹
¹Dept. of Surgery, Medical University of Vienna, Vienna, Austria; ²Clin. Inst. of Pathology, Medical University of Vienna, Vienna, Austria; ³Dept. of Internal Medicine III, Medical University of Vienna, Vienna, Austria; ⁴Dept. of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
Background: Donor-specific antibodies (DSA) are recognized as important factors in determining outcome in renal transplantation.Typically DSAs of the IgG isotype are measured, but little is…